BEAM
BEAM
US07373V1052
Beam Therapeutics Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 139.743.000 63.518.000
120.0%
Cost of Revenue -- --
--
Gross Profit -- --
--
523.436.000 479.086.000
9.3%
Operating Income -383.693.000 -415.568.000
7.7%
Pretax Income -79.992.000 -376.703.000
78.8%
Net Income Common Stockholders -79.992.000 -376.742.000
78.8%
-- --
--
-- --
--
ende